BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Catalano A, Iacopetta D, Ceramella J, Mariconda A, Rosano C, Scumaci D, Saturnino C, Longo P, Sinicropi MS. New Achievements for the Treatment of Triple-Negative Breast Cancer. Applied Sciences 2022;12:5554. [DOI: 10.3390/app12115554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui X, Liu R, Duan L, Zhang Q, Cao D, Zhang A. Exogenous hydrogen sulfide (H2S) exerts therapeutic potential in triple-negative breast cancer by affecting cell cycle and DNA replication pathway. Biomedicine & Pharmacotherapy 2023;161:114488. [DOI: 10.1016/j.biopha.2023.114488] [Reference Citation Analysis]
2 Ceramella J, Iacopetta D, Caruso A, Mariconda A, Petrou A, Geronikaki A, Rosano C, Saturnino C, Catalano A, Longo P, Sinicropi MS. 5,8-Dimethyl-9H-carbazole Derivatives Blocking hTopo I Activity and Actin Dynamics. Pharmaceuticals 2023;16:353. [DOI: 10.3390/ph16030353] [Reference Citation Analysis]
3 Kudelova E, Smolar M, Holubekova V, Hornakova A, Dvorska D, Lucansky V, Koklesova L, Kudela E, Kubatka P. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. Int J Mol Sci 2022;23. [PMID: 36499265 DOI: 10.3390/ijms232314937] [Reference Citation Analysis]